Expression of angiopoietin-2 by human endometrial endothelial cells: Regulation by hypoxia and inflammation

被引:85
作者
Krikun, G [1 ]
Schatz, F
Finlay, T
Kadner, S
Mesia, A
Gerrets, R
Lockwood, CJ
机构
[1] NYU, Sch Med, Dept Obstet & Gynecol, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA
[3] NYU, Sch Med, Dept Pediat, New York, NY 10016 USA
关键词
D O I
10.1006/bbrc.2000.3277
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The functional endometrial layer receives the implanting blastocyst, but is sloughed off during menstruation. Angiogenesis regulates growth and repair of cycling human endometrium. While vascular endothelial growth factor initiates angiogenesis, the angio-poietins (Angs) acting: via the Tie2 receptor, are key regulators of subsequent angiogenic steps. This study is the first to localize Ang-a and Tie2 in human endometrium and to study Ang-2 regulation in cultured human endometrial endothelial cells (HEECs). Immunohistochemistry revealed that expression of Ang-2 and Tie2 was absent from the glands, low in stromal cells, and intense in the endothelial cells. In contrast, only weak expression of Ang-l was detected. The phase of the menstrual cycle did not appear to affect the expression of Ang-2 or Tie2. In vitro studies were carried out utilizing isolated HEECs, the most relevant model for endometrial microvascular biology studies. Both hypoxia and phorbol-myristate-acetate enhanced Ang-a mRNA levels in HEECs. These results suggest that Ang-a plays a role in endometrial pathologies complicated by impaired blood how and inflammation. (C) 2000 Academic Press.
引用
收藏
页码:159 / 163
页数:5
相关论文
共 22 条
[1]   Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning [J].
Davis, S ;
Aldrich, TH ;
Jones, PF ;
Acheson, A ;
Compton, DL ;
Jain, V ;
Ryan, TE ;
Bruno, J ;
Radziejewski, C ;
Maisonpierre, PC ;
Yancopoulos, GD .
CELL, 1996, 87 (07) :1161-1169
[2]   Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development [J].
Dunk, C ;
Shams, M ;
Nijjar, S ;
Rhaman, M ;
Qiu, Y ;
Bussolati, B ;
Ahmed, A .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (06) :2185-2199
[3]   Molecular and biological properties of vascular endothelial growth factor [J].
Ferrara, N .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (07) :527-543
[4]   ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31
[5]   Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development [J].
Gale, NW ;
Yancopoulos, GD .
GENES & DEVELOPMENT, 1999, 13 (09) :1055-1066
[6]   Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: a receptor ligand model for vascular remodelling [J].
Goldman-Wohl, DS ;
Ariel, I ;
Greenfield, C ;
Lavy, Y ;
Yagel, S .
MOLECULAR HUMAN REPRODUCTION, 2000, 6 (01) :81-87
[7]   New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF [J].
Holash, J ;
Wiegand, SJ ;
Yancopoulos, GD .
ONCOGENE, 1999, 18 (38) :5356-5362
[8]   Characterization and expression of a novel alternatively spliced human angiopoietin-2 [J].
Kim, I ;
Kim, JH ;
Ryu, YS ;
Jung, SH ;
Nah, JJ ;
Koh, GY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (24) :18550-18556
[9]   Tumor necrosis factor-α upregulates angiopoietin-2 in human umbilical vein endothelial cells [J].
Kim, I ;
Kim, JH ;
Ryu, YS ;
Liu, M ;
Koh, GY .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (02) :361-365
[10]   PROGESTATIONAL REGULATION OF HUMAN ENDOMETRIAL STROMAL CELL TISSUE FACTOR EXPRESSION DURING DECIDUALIZATION [J].
LOCKWOOD, CJ ;
NEMERSON, Y ;
GULLER, S ;
KRIKUN, G ;
ALVAREZ, M ;
HAUSKNECHT, V ;
GURPIDE, E ;
SCHATZ, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (01) :231-236